VKH
SNOA icon

Virtu KCG Holdings’s Sonoma Pharmaceuticals SNOA Stock Holding History

Virtu KCG Holdings’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-73
Closed -$94K – 3449
2017
Q1 		$94K Buy
+73
New +$84.9K ﹤0.01% 2701
2016
Q2 		– Sell
-23
Closed -$19K – 3310
2016
Q1 		$19K Buy
+23
New +$21.4K ﹤0.01% 2600
2015
Q2 		– Sell
-47
Closed -$36K – 3715
2015
Q1 		$36K Buy
47
+25
+114% +$21.2K ﹤0.01% 2880
2014
Q4 		$28K Buy
+22
New +$34.3K ﹤0.01% 3555
2014
Q2 		– Sell
-19
Closed -$65K – 4026
2014
Q1 		$65K Buy
19
+4
+27% +$13.6K ﹤0.01% 3293
2013
Q4 		$46K Buy
+15
New +$39.9K ﹤0.01% 3615

Other funds holding SNOA

BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Virtu KCG Holdings's SNOA Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Sonoma Pharmaceuticals (SNOA) in Q2 2017, closing a stake of 73 shares — an estimated $94K sold.

Virtu KCG Holdings first reported a position in SNOA in Q4 2013 and held it in 6 quarters. The position peaked at $94K in Q1 2017. 16 funds tracked by Wall St. Rank hold SNOA as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Sonoma Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 73 Sonoma Pharmaceuticals shares in Q2 2017, an estimated $94K.
  • Virtu KCG Holdings first reported a position in Sonoma Pharmaceuticals in Q4 2013 and held it in 6 quarters.
  • Virtu KCG Holdings's Sonoma Pharmaceuticals position peaked at $94K in Q1 2017.
  • 16 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.